{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:15:35Z","timestamp":1788459335034,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cpcardiol.2022.101156","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T18:09:29Z","timestamp":1645294169000},"page":"101156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["The Pathophysiological Basis of Diabetic Cardiomyopathy Development"],"prefix":"10.1016","volume":"47","author":[{"given":"Ashot","family":"Avagimyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Shalnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"322","key":"10.1016\/j.cpcardiol.2022.101156_bib0001","first-page":"145","article-title":"The molecular mechanism of diabetes mellitus - related impairment of cardiovascular homeostasis (review)","volume":"1","author":"Avagimyan","year":"2022","journal-title":"Georgian Med News"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0002","article-title":"Anthracycline associated disturbances of cardiovascular homeostasis","author":"Avagimyan","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0003","article-title":"Hyperhomocysteinemia as a link of chemotherapy-related endothelium impairment","author":"Avagimyan","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0004","article-title":"AC-mode of chemotherapy as a trigger of cardiac syndrome x: a case study","author":"Avagimyan","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0005","article-title":"Chemotherapy, hypothyroidism and oral dysbiosis as a novel risk factor of cardiovascular pathology development","author":"Avagimyan","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0006","first-page":"69","article-title":"The atherogenic impact of oral cavity disbiosis","volume":"304-305","author":"Avagimyan","year":"2020","journal-title":"Georgian Med News"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0007","doi-asserted-by":"crossref","unstructured":"Avagimyan AA, Mkrtchyan LH, Gevorkyan AA, et al. Relationship between chemotherapy and atrial fibrillation: clinical case. rational pharmacotherapy in cardiology. 2021;17:785-791. https:\/\/doi.org\/10.20996\/1819-6446-2021-10-17.","DOI":"10.20996\/1819-6446-2021-10-17"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0008","article-title":"Urotensin-II as a promising key-point of cardiovascular disturbances sequel","author":"Avagimyan","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0009","first-page":"253","article-title":"Influence of exam stress on the development of stress-induced diseases of the cardiovascular system among students","volume":"12","author":"Avagimyan","year":"2020","journal-title":"Kardiologija v Belarusi"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0010","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac Energy Metabolism in Heart Failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0011","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/CIRCRESAHA.108.193326","article-title":"Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium","volume":"104","author":"Borb\u00e9ly","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0012","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0013","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.yjmcc.2010.02.012","article-title":"Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy","volume":"48","author":"Kr\u00fcger","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0014","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-0716-1558-4_17","article-title":"qRT-PCR Analysis of GLUT-4 and assessment of trolox as an effective antioxidant in diabetic cardiomyoblasts","volume":"2343","author":"Asha Devi","year":"2022","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0015","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.7150\/ijbs.48437","article-title":"E3 Ubiquitin ligase NEDD4 family\u2011regulatory network in cardiovascular disease","volume":"16","author":"Zhang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0016","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-319-48382-5_8","article-title":"What Is lipotoxicity?","volume":"960","author":"Engin","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0017","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","article-title":"CD36 deficiency rescues lipotoxic cardiomyopathy","volume":"100","author":"Yang","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0018","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2337\/db20-0921","article-title":"SGLT2 inhibition does not affect myocardial fatty acid oxidation or uptake, but reduces myocardial glucose uptake and blood flow in individuals with type 2 diabetes: a randomized double-blind, placebo-controlled crossover trial","volume":"70","author":"Lauritsen","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0019","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.redox.2017.12.019","article-title":"Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission","volume":"15","author":"Zhou","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0021","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/ijms17071037","article-title":"The role of p38 MAPK in the development of diabetic cardiomyopathy","volume":"17","author":"Wang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0022","article-title":"Fructose-Induced Alteration of the Heart and Vessels Homeostasis","author":"Sukiasyan","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0023","article-title":"Diabefit as a modifier of fructose-induced impairment of cardio-vascular system","author":"Avagimyan","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4142\/jvs.2017.18.3.261","article-title":"Calcium homeostasis in diabetes mellitus","volume":"18","author":"Ahn","year":"2017","journal-title":"J Vet Sci"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0025","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","article-title":"The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis","volume":"92","author":"Pittas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0026","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12933-020-01188-0","article-title":"Impact of peroxisome proliferator-activated receptor-\u03b1 on diabetic cardiomyopathy","volume":"20","author":"Wang","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.120.316738","article-title":"KLF5 Is induced by FOXO1 and causes oxidative stress and diabetic cardiomyopathy","volume":"128","author":"Kyriazis","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0028","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00395-020-00834-8","article-title":"Hyperglycemia regulates cardiac K+ channels via O-GlcNAc-CaMKII and NOX2-ROS-PKC pathways","volume":"115","author":"Hegyi","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tibs.2010.04.005","article-title":"O-GlcNAc signaling: a metabolic link between diabetes and cancer?","volume":"35","author":"Slawson","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0031","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomized controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0032","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0033","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/abbs\/gmz142","article-title":"Resveratrol attenuates diabetes-associated cell centrosome amplification via inhibiting the PKC\u03b1-p38 to c-myc\/c-jun pathway","volume":"52","author":"Wu","year":"2020","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7489795","article-title":"Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications","volume":"2020","author":"Papachristoforou","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6809703","article-title":"The role of AGE\/RAGE signaling in diabetes-mediated vascular calcification","author":"Kay","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0036","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1152\/ajprenal.00186.2009","article-title":"S6 kinase 1 knockout inhibits uninephrectomy or diabetes-induced renal hypertrophy","volume":"297","author":"Chen","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0037","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.metabol.2018.03.004","article-title":"Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-\u03baB pathway","volume":"83","author":"Chen","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0038","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0039","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijbiomac.2018.11.190","article-title":"Involvement of Nrf2 in myocardial ischemia and reperfusion injury","volume":"125","author":"Shen","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2018.01.024","article-title":"ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection","volume":"117","author":"Cadenas","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0041","first-page":"65","article-title":"Upregulation of CREM\/ICER suppresses wound endothelial CRE-HIF-1\u03b1-VEGF-dependent signaling and impairs angiogenesis in type 2 diabetes","volume":"8","author":"Bitar","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0042","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021037533","article-title":"Pathogenesis of diabetic cardiomyopathy and role of miRNA","volume":"31","author":"Ahmed","year":"2021","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0043","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.3390\/ijms21124370","article-title":"MicroRNA and ROS crosstalk in cardiac and pulmonary diseases","volume":"21","author":"Climent","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12933-018-0684-1","article-title":"Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides","volume":"17","author":"Ghosh","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.767488","article-title":"Exosomes in cardiovascular diseases: pathological potential of nano-messenger","volume":"8","author":"Jadli","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2022.101156_bib0046","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2337\/db15-1563","article-title":"Hsp20-Mediated activation of exosome biogenesis in cardiomyocytes improves cardiac function and angiogenesis in diabetic mice","volume":"65","author":"Wang","year":"2016","journal-title":"Diabetes"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:59:56Z","timestamp":1758938396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280622000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0146280622000536"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101156","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pathophysiological Basis of Diabetic Cardiomyopathy Development","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101156"}}